GlobalData on MSN2mon
FDA clears ALK’s AccuTest devices for allergy skin testing
Based in Denmark, ALK is engaged in the marketing of allergy immunotherapy treatments and other products and services. "FDA ...
manilatimes13d
ALK - Financial calendar for the 2025 financial year
It markets allergy immunotherapy treatments and other products and services for people with allergy and allergy doctors. Headquartered in Hørsholm, Denmark, ALK employs around 2,900 people worldwide ...
manilatimes22d
ACARIZAX® approved in Europe for treatment of young children
ALK (ALKB:DC / OMX: ALK B) today announced that its European regulatory filing for ACARIZAX ® (house dust mite sublingual allergy immunotherapy tablet) in young children aged five to 11 has been ...
ALK – Financial calendar for the 2025 financial year
January 2025: Silent period 19 February 2025: Annual report 2024 13 March 2025 at 4.00 p.m.: Annual General Meeting to be held at ALK Bøge Allé 1 2970 Hørsholm, Denmark Written requests to have ...